Effect of Naringenin and Beta Carotene on Energy Expenditure
NCT ID: NCT04697355
Last Updated: 2021-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1 participants
INTERVENTIONAL
2021-04-19
2021-08-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Pharmacokinetics of an Extract of Naringenin
NCT03582553
Evaluation of the Antioxidant and Anti-Inflammatory Capacities of the 'Rosy Red Valencia' and 'Olinda Valencia' Sweet Orange Varieties in Healthy Subjects
NCT06944210
Carotenoid Response to the Intake of Vegetables and Fruits
NCT01403844
The Effects of Orange Juice on Plasma Lipids
NCT01350843
The Effects of Orange Juice on Insulin Sensitivity and Plasma Lipids
NCT01201603
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We will conduct the following assessments before the treatment and at the end of eight weeks.
1. Resting metabolic rate
2. Oral glucose tolerance test with glucose and insulin
3. Ambulatory blood pressure
4. Recording of adverse events
5. Body weight
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Naringenin + Beta carotene
Subject will ingest 300 mg naringenin three times/day and 6 mg beta carotene two times/day
naringenin and beta carotene
Subject will ingest 300 mg naringenin three times/day and 6 mg beta carotene two times/day for eight weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
naringenin and beta carotene
Subject will ingest 300 mg naringenin three times/day and 6 mg beta carotene two times/day for eight weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pennington Biomedical Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Frank Greenway
Chief Medical Officer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frank L Greenway, M.D.
Role: PRINCIPAL_INVESTIGATOR
Pennington Biomedical Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Murugesan N, Woodard K, Ramaraju R, Greenway FL, Coulter AA, Rebello CJ. Naringenin Increases Insulin Sensitivity and Metabolic Rate: A Case Study. J Med Food. 2020 Mar;23(3):343-348. doi: 10.1089/jmf.2019.0216. Epub 2019 Oct 31.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB FWA 00006218
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.